Peter Altman

President and CEO at BioCardia Inc.

Sits on 1 board. Last updated September 28, 2026

Time on boards

Boards served
1
Current seats
1
Board service
4 years
Director since
2023

4 years of board service in total across 1 board, counting each seat separately. Longest: BioCardia Inc., 3 years.

BioCardia Inc. Director · President and CEO
3 years · Since 2023

Chief executive roles

BioCardia Inc. · President and CEO
Dates unknown

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Jun 21, 2024 BioCardia Inc. Open-market purchase +500 $3.29 $1,645
Jun 14, 2024 BioCardia Inc. Open-market purchase +500 $3.52 $1,760
Jun 10, 2024 BioCardia Inc. Open-market purchase +1,000 $3.36 $3,360
Apr 19, 2024 BioCardia Inc. Open-market purchase +2,750 $0.37 $1,018
Mar 28, 2024 BioCardia Inc. Open-market purchase +500 $0.39 $195
Feb 13, 2024 BioCardia Inc. Open-market purchase +108,108 $0.46 $49,730
Aug 17, 2023 BioCardia Inc. Grant or award +4,000 $0.87 $3,480
Aug 14, 2023 BioCardia Inc. Grant or award +4,500 $0.88 $3,960
Jun 23, 2023 BioCardia Inc. Grant or award +6,421 $2.34 $15,025
May 31, 2023 BioCardia Inc. Shares withheld for tax −36,821 $1.77 $65,173
May 26, 2023 BioCardia Inc. Open-market purchase +6,200 $1.60 $9,920
May 18, 2023 BioCardia Inc. Grant or award +109,324 $1.70 $185,851
Jan 11, 2022 BioCardia Inc. Open-market purchase +100 $1.87 $187

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.